Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine &lt;i&gt;vs.&lt;/i&gt; Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: &lt;u&gt;S&lt;/u&gt;urvival &lt;u&gt;T&lt;/u&gt;rial &lt;u&gt;U&lt;/u&gt;sing &lt;u&gt;C&lt;/u&gt;yto &lt;u&gt;k&lt;/u&gt;ine Inhibitors)

Lívia Pimenta Bonifácio; Eduardo Ramacciotti; Leandro Barile Agati; Fernando C. Vilar; Anna Christina Tojal da Silva; Paulo Louzada-Junior; Benedito Antonio Lopes da Fonseca; Hayala Cristina Cavenague de Souza; Caroline Candida Carvalho de Oliveira; Valéria Cristina Resende Aguiar; Carlos Augusto de Aguiar Quadros; Cesar Dusilek; Kenji Itinose; Ricardo Gustavo Zill Risson; Lucas Roberto Rivabem Ferreira; Rogério Aparecido Dedivitis; André Sementilli Cortina; Renato Delascio Lopes; Esper Georges Kallas; Fernando Bellissimo-Rodrigues

Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine vs. Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: Survival Trial Using Cyto kine Inhibitors)

SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4095747 issn: 1556-5068

Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati, Fernando C. Vilar, Anna Christina Tojal Da Silva, Paulo Louzada-Junior, Benedito Antonio Lopes Da Fonseca, Hayala Cristina Cavenague De Souza, Caroline Candida Carvalho De Oliveira, Valéria Cristina Resende Aguiar, Carlos Augusto De Aguiar Quadros, Cesar Dusilek, Kenji Itinose, Ricardo Gustavo Zill Risson, Lucas Roberto Rivabem Ferreira, Rogério Aparecido Dedivitis, André Sementilli Cortina, Renato Delascio Lopes, Esper Georges Kallas, Fernando Bellissimo-Rodrigues